SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YellowLegalPad
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy7/18/2007 12:41:24 PM
   of 1182
 
Ignore - Test

VacTrialID:13
CompName:Menarini Group
DrugName:Abagovomab
VacTypeDesc:Anti-Idiotype
CancerCat:Ovarian Cancer
TrialName:Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients (MIMOSA)
Trial Number:NCT00418574
Phase:3
Enroll:870
PartnerID:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00418574?order=1
DrugLink:

=================================

VacTrialID:3
CompName:Hosp - Jonsson Comprehensive Cancer Center
DrugName:Autologous Tumor Lysate-Pulsed Dendritic Cell
VacTypeDesc:Dendritic Cell
CancerCat:Brain
TrialName:Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma
Trial Number:NCT00107185
Phase:1
Enroll:18
PartnerID:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00107185?order=1
DrugLink:

=================================

VacTrialID:2
CompName:Hosp - Jonsson Comprehensive Cancer Center
DrugName:Autologous Tumor Lysate-Pulsed Dendritic Cell
VacTypeDesc:Dendritic Cell
CancerCat:Brain
TrialName:Vaccine Therapy in Treating Patients With Malignant Glioma
Trial Number:NCT00068510
Phase:1
Enroll:18
PartnerID:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00068510?order=2
DrugLink:

=================================

VacTrialID:22
CompName:Celldex Therapeutics
DrugName:CDX-110
VacTypeDesc:Peptide
CancerCat:Brain
TrialName:Phase II/III Study of CDX-110 in Patients With GBM (ACT III)
Trial Number:NCT00458601
Phase:3
Enroll:375
PartnerID:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00458601?order=1
DrugLink:http://www.celldextherapeutics.com/wt/page/cdx_110

=================================

VacTrialID:10
CompName:Peregrine Pharmaceuticals
DrugName:Cotara
VacTypeDesc:Non-Vaccine - Cotara - TNT (tumor necrosis therpy)
CancerCat:Brain
TrialName:Brain Cancer - Glioblastoma
Trial Number:Cotara - India
Phase:2
Enroll:40
PartnerID:
TrialLink:http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-25-2007/0004614602&EDATE=
DrugLink:

=================================

VacTrialID:1
CompName:Northwest Biotherapeutics Inc
DrugName:DCVAX-Brian
VacTypeDesc:Dendritic Cell
CancerCat:Brain
TrialName:Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer
Trial Number:NCT00045968
Phase:2
Enroll:141
PartnerID:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00045968?order=1
DrugLink:http://www.nwbio.com/dcvax_brain.php

=================================

VacTrialID:12
CompName:Pharmexa A/S
DrugName:GV1001
VacTypeDesc:Peptide
CancerCat:Pancreatic
TrialName:Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Trial Number:NCT00425360
Phase:3
Enroll:1110
PartnerID:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00425360?order=3
DrugLink:http://www.pharmexa.com/site.asp?p=506

=================================

VacTrialID:6
CompName:Pharmexa A/S
DrugName:GV1001
VacTypeDesc:Peptide
CancerCat:Pancreatic
TrialName:GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer.
`
Trial Number:NCT00358566
Phase:3
Enroll:520
PartnerID:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00358566?order=1
DrugLink:http://www.pharmexa.com/site.asp?p=506

=================================

VacTrialID:4
CompName:Hosp - University of Pennsylvania - Dr. Czerniecki
DrugName:HER-2/Neu Pulsed DC1 Vaccine
VacTypeDesc:Peptide
CancerCat:Brain
TrialName:Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast
Trial Number:NCT00107211
Phase:1
Enroll:30
PartnerID:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00107211?order=3
DrugLink:

=================================

VacTrialID:15
CompName:GlaxoSmithKline
DrugName:MAGE-A3
VacTypeDesc:Antigen
CancerCat:Lung Cancer
TrialName:GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
Trial Number:NCT00480025
Phase:3
Enroll:2270
PartnerID:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00480025?order=3
DrugLink:http://www.medicalnewstoday.com/articles/73327.php

=================================

VacTrialID:19
CompName:GlaxoSmithKline
DrugName:MAGE-A3
VacTypeDesc:Antigen
CancerCat:Head and Neck
TrialName:MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck
Trial Number:NCT00257738
Phase:1
Enroll:90
PartnerID:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00257738?order=1
DrugLink:http://www.gsk-us.com/ControllerServlet?appId=4&pageId=402&newsid=910

=================================

VacTrialID:8
CompName:MediGene AG
DrugName:NV1020 - Oncolytic Virus
VacTypeDesc:Virus
CancerCat:Brain
TrialName:Brain Cancer - Glioblastoma
Trial Number:NV1020-Glioblastoma - Not Started
Phase:0
Enroll:0
PartnerID:
TrialLink:http://www.labtechnologist.com/news/ng.asp?n=78088-medigene-herpes-cancer-virus-tumours
DrugLink:http://www.medigene.de/englisch/ProjektHSV.php

=================================

VacTrialID:7
CompName:MediGene AG
DrugName:NV1020 - Oncolytic Virus
VacTypeDesc:Virus
CancerCat:Colorectal Cancer
TrialName:Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver
Trial Number:NCT00149396
NCT00149396
Phase:2
Enroll:27
PartnerID:
TrialLink:http://clinicaltrials.gov/ct/show/NCT00149396?order=1
DrugLink:

=================================

VacTrialID:21
CompName:Antigenics
DrugName:Oncophage
VacTypeDesc:Heat Shock Protein
CancerCat:Brain
TrialName:GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
Trial Number:NCT00293423
Phase:1
Enroll:50
PartnerID:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00293423?order=1
DrugLink:http://www.antigenics.com/products/cancer/oncophage/

=================================

VacTrialID:14
CompName:Merck KGaA
DrugName:Stimuvax
VacTypeDesc:Tumor Cell - Autologous
CancerCat:Lung Cancer
TrialName:Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer
Trial Number:NCT00409188
Phase:3
Enroll:1322
PartnerID:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00409188?order=1
DrugLink:http://www.medicalnewstoday.com/articles/63943.php

=================================

VacTrialID:17
CompName:Oxford BioMedica
DrugName:TroVax
VacTypeDesc:Antigen
CancerCat:Renal Cell Carcinoma
TrialName:A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Trial Number:NCT00083941
Phase:2
Enroll:25
PartnerID:SNY
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00083941?order=2
DrugLink:http://www.oxfordbiomedica.co.uk/trovax.htm

=================================

VacTrialID:18
CompName:Oxford BioMedica
DrugName:TroVax
VacTypeDesc:Antigen
CancerCat:Breast Cancer
TrialName:Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission
Trial Number:NCT00227474
Phase:2
Enroll:120
PartnerID:SNY
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00227474?order=3
DrugLink:http://www.oxfordbiomedica.co.uk/trovax.htm

=================================

VacTrialID:16
CompName:Oxford BioMedica
DrugName:TroVax
VacTypeDesc:Antigen
CancerCat:Renal Cell Carcinoma
TrialName:TroVax Renal Immunotherapy Survival Trial
Trial Number:NCT00397345
Phase:3
Enroll:700
PartnerID:SNY
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00397345?order=1
DrugLink:http://www.oxfordbiomedica.co.uk/trovax.htm

=================================

VacTrialID:5
CompName:IDM Pharma, Inc.
DrugName:UVIDEM (IDD-3)
VacTypeDesc:Dendritic Cell
CancerCat:Melanoma
TrialName:Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma
Trial Number:NCT00107159
Phase:2
Enroll:30
PartnerID:SNY
TrialLink:http://clinicaltrials.gov/ct/show/NCT00107159?order=1
DrugLink:

=================================

VacTrialID:20
CompName:Coley Pharmaceutical
DrugName:VaxImmune
VacTypeDesc:Vaccine Adjuvant - VaxImmune
CancerCat:Lung Cancer
TrialName:GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
Trial Number:NCT00480025
Phase:3
Enroll:2270
PartnerID:
TrialLink:http://www.clinicaltrials.gov/ct/show/NCT00480025?order=3
DrugLink:http://money.aol.com/news/articles/_a/coley-pharmaceutical-groups-vaccine/n20070605095209990013

=================================

VacTrialID:23
CompName:Vakzine Projekt Management
DrugName:VPM4001
VacTypeDesc:Tumor Cell - Allogeneic
CancerCat:Prostate
TrialName:Phase I/II Prostate Cancer
Trial Number:Unknown
Phase:2
Enroll:30
PartnerID:
TrialLink:http://www.psa-rising.com/wiredbird/vakzinepm0607.html
DrugLink:http://www.vakzine-manager.de/Allogeneic_Cancer_Va.167.0.html?&L=1#553

=================================
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News